Header Logo

Connection

Ryan Nipp to Carcinoma, Hepatocellular

Back to Details
This is a "connection" page, showing publications Ryan Nipp has written about Carcinoma, Hepatocellular.
Ryan Nipp
Connection Strength
0.160
Carcinoma, Hepatocellular
  1. Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials. ESMO Open. 2020 08; 5(4).
    View in: PubMed
    Score: 0.160
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.